Prolonged Fever: Kawasaki Disease in a Pediatric Patient With COVID-19.
Amy Becker Manion, Alison Lubelchek, Leanne Bensko
PMID 36549986WHAT IT FOUND
A 30-month-old with prolonged fever tested positive for SARS-CoV-2 and met Kawasaki disease criteria.
IVIG, aspirin, steroids, and famotidine were given; coronary artery dilation resolved, but the report cannot separate treatment contributions. Single case, not evidence.
Key findings
01At the first clinic visit, the 30-month-old had 4 days of fever, tested negative for SARS-CoV-2, and was sent home with guidance to return if the fever did not resolve in 24 hr.
02On day 6 of fever, the child tested positive for SARS-CoV-2 and had dry cracked lips, injected sclerae without discharge, rash, and mild swelling in both hands; an infectious disease consultation supported Kawasaki disease criteria.
03After readmission, the left anterior descending artery had a z-score of 3.0, and by day 4 of that hospitalization a repeat echocardiogram showed it was no longer dilated; the course included IVIG, aspirin, methylprednisolone, and famotidine, so the contribution of any single component cannot be separated.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
A case report cannot show that a treatment works for other children, because it describes a single child's course. The child had both SARS-CoV-2 and rhinovirus/enterovirus detected, so it is hard to separate the effects of infection from Kawasaki disease. The initial rapid SARS-CoV-2 test was negative, then positive on day 6, so early testing did not rule out infection. The diagnosis relied on clinical signs and blood tests, not a definitive Kawasaki disease test. Multiple treatments were given together, so the report cannot separate their effects.
The easy way to misread this
Do not read this as proof that IVIG, aspirin, steroids, or famotidine reliably prevent or reverse coronary artery changes. It describes a single child's course, and the fever, rash, and cardiac findings occurred alongside SARS-CoV-2 and rhinovirus/enterovirus.